Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis

This study has been terminated.
(Manufacturer ceased to produce vials used for this study.)
Janssen-Ortho LLC
Information provided by (Responsible Party):
Innovaderm Research Inc. Identifier:
First received: March 18, 2010
Last updated: June 10, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)